(11:04 GMT) Vertex Pharmaceuticals Price Target Raised to $350.00/Share From $330.00 by Baird
Dow Jones Newswires
Vertex Pharmaceuticals Is Maintained at Underperform by Baird
- Sources
- Dow Jones Newswires
- Markets
- Stocks
- Active symbols
- NASDAQ:VRTX
- Language
- English (India)